CDK4 Cancer Research Results
CDK4, Cyclin-dependent kinase 4: Click to Expand ⟱
| Source: |
| Type: |
Cyclin-dependent kinase 4 (CDK4) is a key regulator of the cell cycle, particularly in the transition from the G1 phase to the S phase. Its expression and activity are often altered in various cancers, contributing to tumorigenesis.
CDK4 is frequently overexpressed in various cancers, and its expression levels can serve as a prognostic marker.
|
Bladder, Bladder Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
P53↑, NF-kB↓, TumCP↓, Apoptosis↑, TumCCA↑, P21↑, cycD1/CCND1↓, cycA1/CCNA1↓, CDK4↓, CDK2↓, BAX↑, Bak↑, Bcl-2↓, Bcl-xL↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, Bak↑, 1, BAX↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK2↓, 1, CDK4↓, 1, cycA1/CCNA1↓, 1, cycD1/CCND1↓, 1, P21↑, 1, TumCCA↑, 1,
Migration(tgid=13) ⓘ
TumCP↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 1,
Total Targets: 14
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: CDK4, Cyclin-dependent kinase 4
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:32 Cells:% prod#:% Target#:894 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page